A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations

被引:219
|
作者
Tamborero, David [1 ,2 ]
Rubio-Perez, Carlota [1 ,2 ]
Muinos, Ferran [2 ]
Sabarinathan, Radhakrishnan [2 ]
Piulats, Josep M. [3 ]
Muntasell, Aura [4 ]
Dienstmann, Rodrigo [5 ,6 ]
Lopez-Bigas, Nuria [1 ,2 ,7 ]
Gonzalez-Perez, Abel [1 ,2 ]
机构
[1] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona 08002, Spain
[2] Barcelona Inst Sci & Technol, Inst Res Biomed, Barcelona 08028, Spain
[3] CIBERONC, Dept Med Oncol, Inst Catala Oncol IDIBELL, Barcelona, Spain
[4] Hosp del Mar, Res Inst, Barcelona, Spain
[5] Vali dHebron Inst Oncol, Barcelona, Spain
[6] Sage Bionetworks, Seattle, WA USA
[7] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain
基金
欧洲研究理事会; 美国国家卫生研究院;
关键词
METASTATIC MELANOMA; ACQUIRED-RESISTANCE; TGF-BETA; IMMUNOTHERAPY; MICROENVIRONMENT; BLOCKADE; THERAPY; RESPONSES; EVASION; REVEAL;
D O I
10.1158/1078-0432.CCR-17-3509
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Throughout their development, tumors are challenged by the immune system, and they acquire features to evade its surveillance. A systematic view of these traits, which shed light on how tumors respond to immunotherapies, is still lacking. Experimental Design: Here, we computed the relative abundance of an array of immune cell populations to measure the immune infiltration pattern of 9,174 tumors of 29 solid cancers. We then clustered tumors with similar infiltration pattern to define immunophenotypes. Finally, we identified genomic and transcriptomic traits associated to these immunophenotypes across cancer types. Results: In highly cytotoxic immunophenotypes, we found tumors with low clonal heterogeneity enriched for alterations of genes involved in epigenetic regulation, ubiquitin-mediated proteolysis, antigen presentation, and cell-cell communication, which may drive resistance in combination with the ectopic expression of negative immune checkpoints. Tumors with immunophenotypes of intermediate cytotoxicity are characterized by an upregulation of processes involved in neighboring tissue invasion and remodeling that may foster the recruitment of immunosuppressive cells. Tumors with poorly cytotoxic immunophenotype tend to be of more advanced stages and bear a greater burden of copy number alterations and frequent alterations of cell cycle, hedgehog, beta-catenin, and TGF-beta pathways, which may cause immune depletion. Conclusions: We provide a comprehensive landscape of the characteristics of solid tumors that may influence (or be influenced by) the characteristics of their immune infiltrate. These results may help interpret the response of solid tumors to immunotherapies and guide the development of novel drug combination strategies. (C) 2018 AACR.
引用
收藏
页码:3717 / 3728
页数:12
相关论文
共 50 条
  • [41] Prediction model for hyperprogressive disease in patients with advanced solid tumors received immune-checkpoint inhibitors: a pan-cancer study
    Long, Yaping
    Yang, Wenyu
    Bai, Yibing
    Tao, Haitao
    Zhang, Fan
    Wang, Lijie
    Yang, Bo
    Huang, Di
    Han, Xiao
    Hu, Yi
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [42] Pan-cancer characterization of tumor-immune interactions using spatially resolved transcriptomics
    Pei, Guangsheng
    Wu, Jingjing
    Dai, Enyu
    Liu, Yunhe
    Han, Guangchun
    Hu, Jian
    Peng, Fuduan
    Cho, Kyung S.
    Jiang, Jiahui
    Zhang, Daiwei
    Sinjab, Ansam F.
    Zhang, Boyu
    Song, Shumei
    Fujimoto, Junya
    Soto, Luisa M. Solis
    Maitra, Anirban
    Ajani, Jaffer
    Li, Mingyao
    Kadara, Humam
    Wang, Linghua
    CANCER RESEARCH, 2023, 83 (07)
  • [43] Single-Cell Analysis of the Pan-Cancer Immune Microenvironment and scTIME Portal
    Hong, Fang
    Meng, Qianqian
    Zhang, Weiyu
    Zheng, Ruiqin
    Li, Xiaoyun
    Cheng, Tao
    Hu, Deqing
    Gao, Xin
    CANCER IMMUNOLOGY RESEARCH, 2021, 9 (08) : 939 - 951
  • [44] Repurposing CAR targets in solid tumors from pan-cancer single-cell RNA-seq data
    Madan, Sanna
    Schaffer, Alejandro
    Ruppin, Eytan
    CANCER RESEARCH, 2022, 82 (12)
  • [45] The pan-cancer, pan-biomarker landscape for precision immuno-oncology.
    McLeod, Howard L.
    Berglund, Anders E.
    Yao, Jiqiang
    Avedon, Melissa
    Teer, Jamie K.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [46] An Integrative Pan-Cancer Analysis of PBK in Human Tumors
    Wen, Huantao
    Chen, Zitao
    Li, Min
    Huang, Qiongzhen
    Deng, Yuhao
    Zheng, Jiawei
    Xiong, Moliang
    Wang, Pengfei
    Zhang, Wangming
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [47] Pan-Cancer Analysis of the Solute Carrier Family 39 Genes in Relation to Oncogenic, Immune Infiltrating, and Therapeutic Targets
    Qu, Yi-Yuan
    Guo, Rong-Yan
    Luo, Meng-Ling
    Zhou, Quan
    FRONTIERS IN GENETICS, 2021, 12
  • [48] Pan-cancer bioinformatics analysis of TIPRL in human tumors
    Xuezhong Zhang
    Hao Xue
    Yuanyuan Lv
    Yuntao Zhou
    Kaihui Sha
    Tonggang Liu
    Discover Oncology, 16 (1)
  • [49] Pan-cancer single-cell landscape of drug-metabolizing enzyme genes
    Mao, Wei
    Zhou, Tao
    Zhang, Feng
    Qian, Maoxiang
    Xie, Jianqiang
    Li, Zhengyan
    Shu, Yang
    Li, Yuan
    Xu, Heng
    PHARMACOGENETICS AND GENOMICS, 2024, 34 (07): : 217 - 225
  • [50] The pan-cancer landscape of glutamate and glutamine metabolism: A comprehensive bioinformatic analysis across 32 solid cancer types
    Xue, Wenhua
    Wu, Kai
    Guo, Xiaona
    Chen, Chengxin
    Huang, Tao
    Li, Lifeng
    Liu, Bin
    Chang, Hao
    Zhao, Jie
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (02):